Centers for Medicare and Medicaid Services (CMS): Proposed Changes to the Hospital Outpatient Prospective Payment System and CY 2011 Payment Rates

BIO is pleased that CMS proposes to reimburse all separately payable drugs and biologicals at average sales price (ASP) plus six percent in 2011 and that the agency has recognized and addressed some of the problems with its rate-setting methodology for drugs and biologicals. We continue to be concerned about problems in CMS‘s methodology that continue to create instability in reimbursement for separately payable drugs and biologicals.

Read the comments